IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally.
Iradimed stock last closed at $51.77, down 0.37% from the previous day, and has increased 27.92% in one year. It has overperformed other stocks in the Medical Devices industry by 0.46 percentage points. Iradimed stock is currently +27.67% from its 52-week low of $40.55, and -18.2% from its 52-week high of $63.29.
There are currently 12.72M shares of IRMD outstanding. The market cap of IRMD is $658.26M. In the last 24 hours, 32,073 IRMD shares were traded.
How to Buy Iradimed Stock
Wondering how to invest in Iradimed stock? Here's how.
Choose where to buy Iradimed stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you choose where to buy Iradimed stock.
Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Put funds into your brokerage account: Select your payment method and add your information.
Evaluate Iradimed stock: The Iradimed ticker symbol is IRMD. Is Iradimed stock a good investment? Should you buy shares of IRMD? How do IRMD's underlying business fundamentals look? Do top analysts think Iradimed is a good buy? Why has IRMD's stock price moved recently? (Hint: Our stock market research website can help you evaluate if IRMD is a good stock to buy).
Make your IRMD buy order: Decide if you will purchase IRMD shares at the current market price or use a limit order to buy IRMD stock at a given price.
Watch your IRMD investment: Create a watchlist to important notifications about your position in Iradimed shares.
Step 1: Choose where to buy Iradimed stock
You will need an online brokerage account in order to access the NASDAQ market and buy IRMD stock.
A brokerage account is an investment account that enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to global markets: From Tech to Financial Services, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've selected your brokerage, it's time to fill out some personal information so you are able to invest in IRMD today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Iradimed stock
After you have selected the best place to buy Iradimed stock, it's important to research their stock prior to buying, so you truly understand the risk as well as the upside.
Iradimed stock data
IRMD Price
$51.77
1w %
3.33%
1y %
27.92%
5y %
155.65%
P/E
34.06x
P/B
7.58x
P/S
8.96x
PEG
4.57x
Revenue
$73.24M
Earnings
$19.23M
Fore. Rev. Growth
10.33%
Fore. Earn. Growth
9.21%
Market Cap
$658.26M
Next Earnings
Apr 30, 2025
Next Dividend
N/A
Iradimed Fundamentals
WallStreetZen was designed to help part-time investors perform more accurate fundamental analysis.
Last year, IRMD earnings were $19.23M. During the past 5 year, IRMD's earnings have gone up by 12.33% per year. This was faster than the Medical Devices industry average of 10.26%.
Last year, IRMD revenue was $73.24M. During the last five year, IRMD's revenue has gone up by 13.72% per year. This was faster than the Medical Devices industry average of 9.92%.
Iradimed pays a dividend of 1.2%, compared to the Medical Devices industry's average dividend yield of 1.3%. If you owned $1,000 worth of IRMD stock, you would have received $11.98 in the past 12 months.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your IRMD buy order
You have two primary order types:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are mostly the easiest way to buy.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at a particular price limit, use a limit order.
Hit the Open button and eToro will execute your order.
If you need more help with buying stocks on eToro, watch the helpful video below:
As of Apr 17, 2025, it costs $51.77 to buy one share of Iradimed stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.193 shares of IRMD.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.